Kretz-Rommel et al elaborated a tumor model on the basis of the previous demonstration that CD200 is up-regulated in CLL and that the up-regulation in multiple myeloma (MM) and acute myeloid leukemia (AML) correlates with adverse prognosis (20–22). The gene discussed is CD200; the disease is neoplasm.